Deep, focused next-technology sequencing has revealed that subclonal mutations (i.e., Those people present in just a fraction of tumor cells) is usually detected for all driver genes and are related to quick ailment progression and inadequate end result.11–thirteen This is especially appropriate for TP53 mutations given the fact that, as defined